Patient rights in precision oncology: right treatment, right time, right dose, right order, right place

Genome Medicine · Published 2025-05-12 · Journal article · DOI 10.1186/s13073-025-01468-y · PMID: 40355948 · PMC · Cited by 6 (Crossref)

Free full text

Authors (3)

Elena Fountzilas, Apostolia-Maria Tsimberidou, Razelle Kurzrock

Abstract

Abstract Precision oncology has facilitated a transition from a one-size-fits-all to a precise individualized approach. This Comment discusses the broader challenges in the implementation of personalized treatments to further improve patients’ outcomes, towards comprehensive strategies that address tumor complexity and patients’ molecular portfolios, as well as quality of life and diversity considerations.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Volume

17

Issue

1

Year

2025

Citation

Fountzilas, E., Tsimberidou, A., Kurzrock, R. (2025). Patient rights in precision oncology: right treatment, right time, right dose, right order, right place. Genome Medicine. https://doi.org/10.1186/s13073-025-01468-y

Related articles

• Decoding the microbiome: artificial intelligence-targeted gut microenvironment breakthroughs in personalized cancer therapy · Gut Microbes · 2026 · Cites or is cited by this article
• Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy · MedComm · 2026 · Cites or is cited by this article
• Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer · Genome Medicine · 2026 · Same journal
• Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience · Genome Medicine · 2026 · Same journal
• Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer · Genome Medicine · 2026 · Same journal
• Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases · Genome Medicine · 2026 · Same journal
• Long-read transcriptome sequencing and Drosophila-based functional validation reveal novel gene fusions in fusion panel-negative gliomas · Genome Medicine · 2026 · Same journal
• Comprehensive genomic characterization of extraintestinal pathogenic Escherichia coli isolated from neonates: multiple center insights into virulence, resistance, and transmission dynamics · Genome Medicine · 2026 · Same journal
• Infiltrating monocyte-derived macrophages does not survive long term in stroke brain despite their dominance in the acute ischemic core and myeloid derived IGF-1 play dichotomous roles in stroke recovery · Genome Medicine · 2026 · Same journal
• Multifeature sequencing-based liquid biopsy for cancer diagnosis and monitoring · Genome Medicine · 2026 · Same journal

Metrics

Citations (Crossref)

6